Search for Joe Jimenez and
    1. June 7, 2015

      Novartis chief backs shake-up in drug pricing

      Pharmaceutical companies must move towards new pricing models based on outcomes for patients if Europe’s cash-strapped...

    2. April 23, 2015

      Novartis starts to reap rewards of revamp

      Novartis announced better than expected first-quarter profits on Thursday as it began to show the benefits of a sweeping...

    1. March 22, 2015

      Apple and Google stake a claim on big pharma’s turf

      Within 24 hours of Apple launching its platform for health research this month, tens of thousands of iPhone users had signed...

    2. March 8, 2015

      Novartis leads way for big pharma cost-cuts

      Novartis is showing the way for big pharmaceutical groups to become more productive, according to its chief executive, as...

    3. March 2, 2015

      GSK-Novartis deal ‘a model’ for industry

      A $2bn disposal by Johnson & Johnson and the completion of a $20bn asset swap between GlaxoSmithKline and Novartis on Monday...

    4. January 27, 2015

      Novartis vows cost cuts after Swiss franc surge

      Novartis has leapt to the defence of the Swiss National Bank for removing the cap on the Swiss franc against the euro and...

    5. July 17, 2014

      Novartis maintains forecasts despite weak quarter

      Novartis confirmed its full-year profit and revenue forecasts, despite weaker than expected second-quarter results and the...

    6. April 24, 2014

      Novartis profits boosted by sales in emerging markets

      Novartis posted a 23 per cent jump in net profits in the first quarter, thanks to the sale of one of its diagnostics units,...

    7. April 22, 2014

      GSK chief quick to distance Novartis deal from megamerger mania

      Another day, another big pharma deal. Novartis and GlaxoSmithKline became the latest companies to join the industry’s...

    8. April 22, 2014

      Novartis chief Joe Jimenez makes biggest move at group

      The multibillion-dollar reshaping of Novartis announced on Tuesday is easily the most significant move that Joe Jimenez, the...

    9. April 22, 2014

      Novartis buys GSK business for up to $16bn in restructuring

      Novartis and GlaxoSmithKline have agreed to swap a series of assets in a multibillion-dollar deal that will reshape two of...

    10. April 2, 2014

      Big pharma’s rise in China not held back by scandals

      When Chinese authorities accused GlaxoSmithKline last summer of being the “godfather” at the centre of a network of...

    11. March 10, 2014

      Novartis restructure marks break from expansion

      It is four years since Joe Jimenez took over as chief executive of Novartis. But, in some ways, it feels as if he is only...

    12. February 16, 2014

      Novartis puts pressure on India over patent abuse

      Novartis has urged US and European governments to “apply pressure” on India to respect intellectual property and warned New...

    13. February 13, 2014

      Recent votes call into question Swiss hospitality to business

      Few countries have been more hospitable to business than Switzerland. Its stable laws and favourable tax regime have proved...

    14. January 29, 2014

      Novartis considers future of $14bn Roche stake

      Novartis’s $14bn stake in its local rival Roche is one of the assets it is scrutinising as part of a broader review of its...

    15. December 8, 2013

      Change without sour grapes

      When Jörg Reinhardt rejoined Novartis in August to take up his new role as chairman of the Swiss pharmaceutical group, he...

    16. November 11, 2013

      Novartis agrees $1.7bn sale of blood diagnostics unit to Grifols

      Novartis has agreed to sell its blood diagnostics unit to the Spanish healthcare group Grifols for $1.7bn, in the first of a...

    17. June 17, 2013

      Novartis pioneers health project in rural China

      China may be one of the world’s largest markets for companies from Rolls-Royce to Rolex, but beneath that veneer of wealth...

    18. February 24, 2013

      Novartis’ U-turn marks a crossroads

      Daniel Vasella may have struggled at first to speak English when he was sent to the US on his first pharmaceutical industry...

    19. January 23, 2013

      Vasella to step down as Novartis chairman

      Shares jumped sharply at Novartis on anticipation of a shift in strategy at the Swiss healthcare group, following the abrupt...

    20. July 19, 2012

      Novartis offsets effects of patent expiry

      Novartis reported second-quarter net income unchanged at $2.7bn and maintained existing full-year 2012 guidance, despite...

    21. April 26, 2012

      Simon Lowth, interim CEO AstraZeneca

      Simon Lowth’s appointment as interim chief executive of AstraZeneca puts him in a strong position as the long-term successor...

    22. February 5, 2012

      Pharma seeks to ease pain of euro crisis

      With Greece and Spain struggling to repay billions of euros in outstanding debts to the healthcare sector as the eurozone...

    23. January 25, 2012

      Novartis upbeat despite end of Diovan patent

      Novartis forecast it would maintain sales and suffer only potentially slightly lower operating profits this year, despite...

    24. October 25, 2011

      Novartis to cut 10% of Swiss workforce

      Novartis will cut its core Swiss workforce by almost 10 per cent, in the latest attempt by a top pharmaceuticals group to...

    25. June 27, 2011

      China: Pharma heads east for profit

      After 30 years of economic reform in China, the growing middle class is discovering there is more to life than working – and...

    26. April 19, 2011

      Novartis profit hit by costs of Alcon buy-out

      Novartis boosted sales in the first quarter, but the Swiss pharmaceuticals group’s net profits fell because of higher...

    27. March 16, 2011

      Novartis plans to close drugs factory

      Novartis has dealt a fresh blow to the UK’s historical strength in the pharmaceutical sector with plans to reduce...

    28. January 27, 2011

      Novartis confident despite market pressures

      Novartis remains optimistic about the current year, in spite of intensifying pricing pressure in many markets as stretched...

    29. December 15, 2010

      Novartis climbs down to clinch Alcon

      Novartis has backed down in its battle with the independent directors of Alcon by agreeing to pay an extra $1bn to buy out...

    30. November 17, 2010

      Novartis looks beyond pills in latest drive

      Novartis aims to generate a “substantial” proportion of its future drug sales from contracts directly linked to improved...

    31. November 15, 2010

      Novartis closes in on growth formula

      Novartis could be back on the takeover trail within the next four years as debt from its $50bn acquisition of Alcon falls...

    32. October 21, 2010

      Novartis results lifted by new products

      Novartis demonstrated the benefits of continuing efficiency improvements and a strong pipeline of new drugs, as the Swiss...

    33. July 15, 2010

      Novartis raises outlook on 19% profits rise

      Novartis kicked off the European pharmaceuticals reporting season on Thursday with solid rises in sales and earnings on the...

    34. June 11, 2010

      The last word: Why researchers are no longer moving from the lab to the boardroom

      Wanted: chief executive for pharmaceutical company to bring lucrative new medicines to market. Scientists need not apply....

    35. June 10, 2010

      Researchers are out of race for the top job

      Wanted: chief executive for pharmaceutical company to bring lucrative new medicines to market. Scientists need not apply....

    36. May 10, 2010

      From fast moving goods to making drugs faster

      Joe Jimenez greets his visitor in an imposing but anonymous meeting room at Novartis's Basel headquarters. The setting could...

    37. May 9, 2010

      Making drugs faster

      Joe Jimenez greets his visitor in an imposing but anonymous meeting room at Novartis’s Basel headquarters. The setting could...

    38. April 21, 2010

      Swine flu vaccine boosts Novartis

      Novartis, the Swiss pharmaceuticals group, reported a large jump in first-quarter earnings boosted by strong sales of its...

    Search for Joe Jimenez and